CXCL10 and neoplasm: A spatially distributed microneedle system (SDMNS) comprises two dissolving microneedles: DBCO‐αCD3/28@MNs, which activate T cells and label them with bioorthogonal groups in lymph nodes, and IP10‐Az@MNs, which label tumor cells and guide T cell migration.